Genetic Predisposition
93
27
33
34
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
4.3%
4 terminated out of 93 trials
89.5%
+3.0% vs benchmark
3%
3 trials in Phase 3/4
12%
4 of 34 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 34 completed trials
Clinical Trials (93)
Diagnostic Value of Exome/ Genome Sequencing, Conventional Methods in Rare Diseases and Familial Tumor Syndromes
Vascular Disease Discovery Protocol
Pre Pectoral Implant for Immediate Breast Reconstruction Using Single Port Endoscopy in Prophylactic Indication
Enhancing Information Management for Young Adults After Genetic Cancer Risk Testing
Barriers and Facilitators of Parent-Child Communication in Children With Cancer Predisposition
Outcomes of Health Care Transition for AYA With a Cancer Predisposition
Pancreatic Cancer Early Detection Consortium
COMT Activity and Hypnotizability
Prospective Evaluation on Cognitive Function and Its Associated Genetic Vulnerability in Cannabis Users
The Preventive Risk Outreach And Cascade Testing
Mayo Clinic Precure - Prospective Study
Growing Up in Singapore Towards Healthy Outcomes
The Effect of rs7903146 Genotype on Islet GLP-1 Production in Humans
Genetic Investigation of Cancer Predisposition
Care Plans for Cancer Predisposition
Precision Medicine in the Prostate Cancer Care Pathway
Understanding Gene ENvironment Interaction in ALcohol-related Hepatocellular Carcinoma
PTX3-targeted Antifungal Prophylaxis
Assessment of Topical Minoxidil on Intraoperative Flap Perfusion and Cutaneous Flap Viability in Breast Recon
Evaluation of Risk of hEpatocellular Carcinoma